MedPath

The effect of Bevacizumab on recurrent pterygia

Phase 2
Conditions
pterygium.
Pterygium
Registration Number
IRCT201010054856N1
Lead Sponsor
Vice Chancellor for research, Baqiyatallah University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Recurrence of pterygia after surgical excision
Exclusion criteria:
History of any other ophthalmic surgery

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pterygium size. Timepoint: Before intervention, 1 week, 1 month and 3 monthes after intervention. Method of measurement: mili meter with Slit Lamp.
Secondary Outcome Measures
NameTimeMethod
Angiogenesis. Timepoint: Befor intervention, 1 week, 1 month and 3 monthes after intervention. Method of measurement: Based on Fondues Camera picture.
© Copyright 2025. All Rights Reserved by MedPath